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Abstract
Background Athina Markou and her colleagues discovered
persistent changes in adult behavior following adolescent ex-
posure to ethanol or nicotine consistent with increased risk for
developing addiction. Building on Dr. Markou’s important
work and that of others in the field, researchers at the
Bowles Center for Alcohol Studies have found that persistent
changes in behavior following adolescent stress or alcohol
exposure may be linked to induction of immune signaling in
brain.
Aim This study aims to illuminate the critical interrelationship
of the innate immune system (e.g., toll-like receptors [TLRs],
high-mobility group box 1 [HMGB1]) in the neurobiology of
addiction.
Method This study reviews the relevant research regarding
the relationship between the innate immune system and
addiction.
Conclusion Emerging evidence indicates that TLRs in brain,
particularly those on microglia, respond to endogenous innate
immune agonists such as HMGB1 and microRNAs
(miRNAs). Multiple TLRs, HMGB1, and miRNAs are in-
duced in the brain by stress, alcohol, and other drugs of abuse
and are increased in the postmortem human alcoholic brain.
Enhanced TLR-innate immune signaling in brain leads to epi-
genetic modifications, alterations in synaptic plasticity, and
loss of neuronal cell populations, which contribute to cogni-
tive and emotive dysfunctions. Addiction involves progres-
sive stages of drug binges and intoxication, withdrawal-
negative affect, and ultimately compulsive drug use and
abuse. Toll-like receptor signaling within cortical-limbic cir-
cuits is modified by alcohol and stress in a manner consistent
with promoting progression through the stages of addiction.
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Introduction
Several studies have found lasting changes in brain that con-
tribute to the progression through the stages of addiction
(Koob and Volkow 2010). Emerging findings suggest that
signaling through known innate immune signaling systems
in brain contributes to mounting negative affect and may un-
derlie the neurobiological similarities of depression and addic-
tion (Markou et al. 1998). Athina Markou and her colleagues
discovered persistent changes in adult behavior following ad-
olescent exposure to ethanol or nicotine consistent with in-
creased risk for developing addiction. For example, adoles-
cent alcohol exposure was shown to increase high-reward
choices even when the probability of reward outcome was
unlikely (i.e., rats exposed to ethanol during adolescence led
to increased risky decision-making in adulthood; Boutros
et al. 2014, 2015). Risky choice preference was found to cor-
relate with the loss of cholinergic neurons in the basal fore-
brain (Boutros et al. 2014). Adolescent ethanol exposure was
also found to increase adult central nucleus of the amygdala
corticotropin-releasing factor (CRF) messenger RNA
(mRNA) 40 days following the last ethanol dose (i.e., a
persistent change in amygdalar CRF levels; Boutros et al.
2016). Similarly, 20 days after the last ethanol exposure, ado-
lescent, but not adult rats, were found to have a long-lasting
decrease in time spent in the open arms of a radial arm maze,
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consistent with deficits in risk-reward integration (Risher et al.
2013). Further, this study found a lasting change in sensitivity
to acute ethanol disruption of working memory (Risher et al.
2013), and another study using delayed discounting found that
acute ethanol weeks after adolescent exposure altered impul-
sivity (Mejia-Toiber et al. 2014). These studies are consistent
with findings indicating that adolescent ethanol exposure al-
ters adult reward responses to ethanol (Boutros et al. 2014).
Taken together, these findings and others are consistent with
adolescent ethanol causing persistent changes in brain that
increase risk for addiction in adulthood (Crews et al. 2016).
These persistent changes in behavior following adolescent
stress or alcohol exposure may be linked to induction of im-
mune signaling in brain.
Over the past decade, the innate immune system has
emerged as a critical component in the development of alcohol
use disorders and other addictions. Microglia, the resident
macrophage-like innate immune cells of the central nervous
system, have only recently been discovered to play a critical
role in brain homeostasis with key roles in neuronal differen-
tiation, synapse formation, and neurocircuitry. It was only
recently discovered that on embryonic day 8 in mice, meso-
dermal progenitor yolk sac cells migrate to brain to form mi-
croglia that persist throughout life as unique brain cells, dis-
tinct from the neuro-ectodermal cells that form neurons and
other glia (e.g., astrocytes and oligodendrocytes) (Ginhoux
et al. 2010, 2013). Originating from the mesoderm, microglia
express a multitude of innate immune signaling receptors and
molecules. One microglia-associated receptor system, the toll-
like receptor (TLR) superfamily (i.e., interleukin-1 receptor/
toll-like receptor), mounts proinflammatory responses to path-
ogens by sensing large molecules containing lipids, sugars,
protein, and nucleic acid components. Initial studies suggested
that only microglia are involved in TLR signaling, but more
recent studies suggest that all brain cell types are involved in
this signaling (Crews and Vetreno 2016). Toll-like receptors
activate signaling cascades that converge on nuclear factor
kappa-light-chain-enhancer of activated B cells (NF-κB), a
key innate immune nuclear transcription factor that promotes
expression of proinflammatory cytokines, including tumor ne-
crosis factor α (TNFα), interleukin-1β (IL-1β), IL-6, and
monocyte chemoattractant protein-1 (MCP-1). Recent studies
in brain, which is normally a sterile environment, indicate that
endogenous TLR agonists may comprise an important signal-
ing pathway between microglia, other glia, and neurons. The
ubiquitously expressed nuclear protein, high-mobility group
box 1 (HMGB1), is a cytokine-like molecule expressed in all
cell types that upon release can directly activate TLRs and
enhance the response of other innate immune signaling mole-
cules at their respective receptors (see Fig. 1). Human and
preclinical animal studies find that stress (Frank et al. 2015),
alcohol (Crews and Vetreno 2014), and other drugs of abuse
(Hutchinson et al. 2010; Northcutt et al. 2015) increase
expression of TLRs and other innate immune signaling mol-
ecules (e.g., HMGB1) in brain. Induction of TLRs and
HMGB1, an endogenous TLR agonist, leads to activation of
positive loops of amplification that result in a progressive and
persistent increase in TLR and HMGB1 signaling. For exam-
ple, expression of HMGB1 and multiple TLRs in the postmor-
tem human orbitofrontal cortex are correlated with lifetime
alcohol consumption in alcoholic and moderate drinking con-
trols (Crews et al. 2013). Cycles of binge drinking may sen-
sitize the brain to promote drinking behavior (see Fig. 2).
Similarly, mechanistic preclinical studies of epilepsy reveal
that neuronal activation causes the rapid release of HMGB1
and IL-1β that occur prior to seizure onset resulting in neuro-
nal sensitization to excitation due to alterations in excitatory
receptor expression as well as lowered seizure threshold lead-
ing to increased seizure frequency and severity with each
event (i.e., Bkindling^; Maroso et al. 2011). While the brain
regions and neural circuits underlying addiction and epilepsy
differ, stress and drug abuse may share a common mechanism
of neurocircuitry sensitization through increased HMGB1 and
TLR signaling.
Preclinical models reveal that ethanol increases the expres-
sion of HMGB1 and TLRs in the brain that persists through
long periods of abstinence (Vetreno and Crews 2012; Vetreno
et al. 2013). Human studies find increased expression of
microglial markers and cytokines as well as HMGB1 and
TLRs in the postmortem alcoholic brain (Crews et al. 2013;
He and Crews 2008; Zou and Crews 2012) with the latter two
correlating with lifetime alcohol consumption (Crews et al.
2013). Repeated stress and cycles of alcohol and drug abuse
sensitize microglia consistent with the hypothesis that induc-
tion of innate immune signaling pathways contributes to the
progressive increase in craving, mood dysfunction, and cog-
nitive impairments observed in addiction. Recent discoveries
indicate that ethanol leads to the induction ofmultiple TLRs as
well as endogenous TLR agonists in brain. While poorly un-
derstood at present, studies suggest that activation and esca-
lated signaling of this system lead to a progressive loss of
behavioral control, increased impulsivity and anxiety, and
negative affect and craving coupled with increasing ventral
striatal responses to promote reward-seeking behaviors and
increase the risk of developing alcohol use disorders.
The innate immune system
While early studies characterized innate immune receptors
based on their response to specific pathogens (e.g., bacteria
and viruses), more recent Bsterile inflammation^ studies in
brain led to the identification of these receptors as pattern
recognition receptors (PRRs). Pattern recognition receptors
have revolutionized our understanding of innate immune sys-
tem signaling in brain. These receptors recognize and respond
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not only to specific molecular patterns present on foreign
(exogenous) pathogens (i.e., pathogen-associated molecular
patterns [PAMPS]) but also to endogenous signaling mole-
cules associated with cell damage, degeneration, or stress
(i.e., danger-associated molecular patterns [DAMPs])
(Bianchi 2007). To date, five classes of PRRs have been char-
acterized: (1) TLRs, (2) C-type lectin receptors, (3)
nucleotide-binding oligomerization domain-like receptors
(NOD-like receptors), (4) RIG-I-like receptors, and (5)
AIM2-like receptors (Brubaker et al. 2015). Although all of
these receptors are important for host defense, the TLR family
of PRRs has most thoroughly been characterized using
inflammagens, such as endotoxin/lipopolysaccharide at
TLR4 and viral RNA at TLR3 and TLR7. Toll-like receptors
share an extracellular N-terminal leucine-rich repeat sequence
and an intracellular toll/interleukin-1 receptor/resistance motif
(TIR; Takeuchi and Akira 2010). Currently, 10 TLRs have
been identified in humans and 12 TLRs have been identified
in mice (Brubaker et al. 2015). All of these PRRs recognize a
variety of PAMPs, including bacterial endotoxin and viral
RNA as well as DAMPs such as mammalian HMGB1,
microRNAs, and heat shock proteins (Vabulas et al. 2002).
Interestingly, DAMP activation of TLRs has been identified
as a contributing factor in several non-infectious neurological
disorders, including alcoholism. For instance, expressions of
TLR2, TLR3, and TLR4 as well as the PRR receptor for
advanced glycation end-products (RAGE) and the TLR/
RAGE endogenous agonist HMGB1 are each increased in
the postmortem human alcoholic orbitofrontal cortex (Crews
et al. 2013; Vetreno et al. 2013). Preclinical models of adoles-
cent binge ethanol treatment find long-term upregulation of
TLR3, TLR4, RAGE, and proinflammatory cytokines in the
adult frontal cortex (Vetreno and Crews 2012) as well as sev-
eral TLRs (TLR1–TLR10 except for TLR9) in the adult cer-
ebellum (see Fig. 3). Immune signaling through TLRs and
other immune signaling receptors induce additional TLRs
and other innate immune signaling agonists and their respec-
tive receptors, which further induce immune signals, creating
Fig. 1 High-mobility group box 1 (HMGB1) signaling involvement in
addiction neuropathology. HMGB1 is actively and/or passively released
from neurons and other cells leading to the activation of multiple innate
immune signaling pathways. Extracellularly, HMGB1 can directly
interact with toll-like receptors (TLRs) or form complexes with various
ligands to enhance immune responses at various pattern recognition
receptors (PPRs). In addition, HMGB1 can form complexes with
nucleic acids and microRNAs (miRNAs; e.g., let-7) that are
endocytosed into the cell-activating intracellular TLRs. Activation of
TLRs and other PRRs leads to activation of the transcription factor
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)
and subsequent induction of proinflammatory cytokines and oxidases that
are released into the extracellular space. Evidence implicates these
cascades in contributing to the progression through the stages of
addiction. LPS lipopolysaccharide, RAGE receptor for advanced
glycation end-products, IL-1β interleukin-1beta
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positive loops of activation that likely amplify and contribute
to the persistence of drug-induced immune signaling.
Similarly, other studies report that chronic ethanol exposure
increases expression of TLR2 in the mouse brain (Fernandez-
Lizarbe et al. 2013; Oak et al. 2006). Thus, both human and
animal studies find that alcohol upregulates the expression of
multiple TLRs.
In order for these innate immune signaling molecules to
remain elevated for extended periods of abstinence, signaling
amplification of these signaling molecules likely occurs.
Ethanol causes activation of the transcription factor NF-κB,
leading to increased PRR expression, cytokine induction, and
DAMP release. This signaling system leads to amplification
of the innate immune response in brain through an autocrine
and paracrine process such that secreted cytokines, DAMPs,
and microRNAs activate receptors on the cells of origin as
well as surrounding cells. In addition, ethanol causes genera-
tion of reactive oxygen species that further activates NF-κB
transcription of cytokines and DAMPs in an autocrine and
paracrine fashion (Pietri et al. 2005; Qin and Crews 2012b;
Thakur et al. 2007). Thus, the gradual induction of inflamma-
tory processes that accompanies repeated binge-drinking epi-
sodes, particularly during adolescence, leads to a progressive
and persistent activation of the innate immune system and
might underlie the transition from alcohol abuse to
alcoholism.
As alluded to above, TLR signaling pathways are quite
complex. Following recognition of a ligand by a specific
TLR, the adaptor protein TIRAP/MyD88, which interacts
with all of the TLRs except TLR3, initiates intracellular sig-
naling cascades leading to downstream activation of IL-1 re-
ceptor-associated kinases (IRAKs) and TNF receptor-
associated factor 6 (TRAF6), which cause IκB and MAPK
activation. Activation of IκB and MAPK in turn leads to
downstream activation of the transcription factor NF-κB and
subsequent cytokine induction (Crews et al. 2013; Lippai et al.
2013b). NF-κB is a critical modulator of innate immune func-
tion, and exposure to stress and drugs of abuse result in NF-κB
activation. For instance, psychosocial stress induces NF-κB
activation in human blood mononuclear cells (Bierhaus et al.
2003). In rodents, restraint stress increases expressions of
Fig. 3 Adolescent intermittent ethanol (AIE) treatment upregulates
expression of toll-like receptors (TLRs) in the adult cerebellum. From
postnatal day (P)25 to P55, AIE-treated male Wistar rats received a
single daily intragastric dose of ethanol (5.0 g/kg, 20% ethanol, w/v) on
a 2-day on/off schedule, and CON subjects received comparable volumes
of water as described previously (Vetreno et al. 2016). Following a 25-day
abstinence period, cerebellar tissue samples were collected on P80. Tissue
samples were processed for qPCR and TLR mRNAs assessed as
previously described (Vetreno and Crews 2012). Data are presented as
mean ± SEM. *p < 0.05
Fig. 2 Lifetime alcohol consumption and HMGB1-TLR expression in
the human postmortem orbitofrontal cortex. Expression of toll-like
receptors (TLRs) 2, 3, and 4 and the TLR endogenous agonist high-
mobility group box 1 (HMGB1) are positively correlated with lifetime
alcohol consumption (kg) (Crews et al. 2013). Moderate drinking
controls are clustered along the left of the graph due to low lifetime
levels of alcohol consumption and concomitant low levels of TLR-
HMGB1 expression. Alcoholic subjects all consumed more alcohol
than moderate drinking controls but show a 10-fold variation in lifetime
alcohol consumption. Note that the x axis is broken to allow for
visualization of the moderate drinking control data. Repeated cycles of
binge drinking are hypothesized to induce a progressive and persistent
shift in the allostatic set point for negative affect that contributes to the
neurobiology of addiction (Koob and Le Moal 2005). Depicted are
correlations for individual TLRs and HMGB1 and overall grouped
correlations with lifetime alcohol consumption
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NF-κB, proinflammatory cytokines, and the proinflammatory
oxidase cyclooxygenase-2 (COX-2) in brain (Madrigal et al.
2002, 2003). Ethanol also activates NF-κB in rat and mouse
brain (Qin and Crews 2012b; Ward et al. 1996), and NF-κB
target genes are upregulated in the postmortem human alcohol
prefrontal cortex (Okvist et al. 2007). Cocaine exposure also
leads to activation of NF-κB in the nucleus accumbens and is
required for the establishment of cocaine-induced, condi-
tioned place preference (Ang et al. 2001a; Russo et al.
2009). Thus, both stress and drugs of abuse lead to activation
of the innate immune transcription factor NF-κB in the brain
that might contribute to innate immune induction.
Innate immunity, TLR signaling, and addiction
There is evidence consistent with the hypothesis that stress-
and drug-induced innate immune upregulation inactivates the
prefrontal cortex and sensitizes limbic circuitry. This suggests
that the progressive and persistent increase of HMGB1-TLR
signaling occurring with each cycle of stress and drug abuse is
the mechanism underlying addiction (Crews et al. 2011;
Vetreno and Crews 2014). Induction of innate immune signal-
ing is known to cause cognitive and emotive dysfunctions in
both preclinical (Dantzer et al. 2008; Hanke and Kielian 2011;
Okun et al. 2010; Yirmiya and Goshen 2011) and human
studies (Brites and Fernandes 2015; Critchley and Harrison
2013; Harrison et al. 2015; Rea et al. 2016). Alcohol and other
drugs of abuse promote innate immune induction (Crews et al.
2016; He and Crews 2008; Qin et al. 2008) that is associated
with alterations in executive function, reinforcement, and af-
fective processes that promote alcohol abuse and addiction
(Vetreno and Crews 2014). Indeed, ethanol induction of innate
immune activation and TLR signaling contribute to brain al-
terations and the development of addiction-like behaviors (Liu
et al. 2011b; Montesinos et al. 2016; Pascual et al. 2011,
2015). For instance, Guerri and colleagues (Pascual et al.
2011) found that binge ethanol-induced innate immune acti-
vation in mice impairs novel object recognition memory and
increases anxiety-like behavior, an effect that is not found in
TLR4 knockout mice. Interestingly, the observed behavioral
impairments in this study were accompanied by reduced H3
and H4 histone acetylation as well as diminished histone ace-
tyltransferase activity in the frontal cortex, striatum, and hip-
pocampus, which was also not observed in TLR4 knockout
mice. The finding that mice lacking TLR4 do not evidence
ethanol-induced changes in epigenetic markers suggests that
TLR-innate immune signaling contributes to drug-induced
epigenetic changes leading to alterations in neurotransmitter
signaling related to addiction. Similarly, adolescent binge eth-
anol exposure increases both ethanol preference and cocaine-
conditioned place preference in young adult rodents, which
was not observed in TLR4 knockout mice (Montesinos et al.
2016) or adult rats following treatment with trichostatin A, a
histone deacetylase inhibitor (Pandey et al. 2015). These find-
ings suggest that TLRs, specifically TLR4 in these experi-
ments, are required for chronic ethanol-induced behavioral
and histone acetylation changes in brain. TLR-innate immune
induction appears to drive epigenetic and behavioral modifi-
cations that likely play a role in the dysfunctional cognitive,
emotive, and reinforcement processes observed in addiction,
since mice lacking TLR4 do not show these ethanol responses
(Montesinos et al. 2016). Although the epigenetic mechanism
underlying these effects is unclear, the data suggest that these
changes might be due in part to increased innate immunity and
diminished neurotropic expression that leads to alterations in
synaptic plasticity (see Fig. 4). Indeed, adolescent intermittent
ethanol (AIE) -induced activation of astrocytes, which are an
important component of the innate immune system (Farina
et al. 2007), is associated with increased expression of
thrombospondins, which regulate synapse formation
(Christopherson et al. 2005) in vitro and in the adult hippo-
campus (Risher et al. 2015). Thus, alcohol exposure may in-
crease neuroplasticity in brain regions associated with addic-
tion. An additional inflammatory pathway mediated by
RAGE might also contribute to addiction and the cognitive
impairments associated with alcoholism. Studies in the post-
mortem human alcoholic brain and AIE model find increased
expression of RAGE in the adult prefrontal cortex (Vetreno
et al. 2013), and this receptor has been implicated in memory
impairments associated with Alzheimer’s disease (Arancio
et al. 2004; Fang et al. 2010; Maczurek et al. 2008; Wilson
et al. 2009). Together, these data connect TLRs, RAGE,
HMGB1, and other innate immune signaling molecules with
epigenetic modifications to drug- and stress-induced changes
in neurobiology that are related to addiction.
Although TLRs are capable of sensing and responding to a
multitude of ligands, HMGB1 has been identified as a critical
mediator of innate immune induction in alcohol abuse.
HMGB1 is a nuclear protein involved in chromatin stabiliza-
tion and acts as a chaperone for various transcription factors
(Thomas and Stott 2012). Following extracellular release,
HMGB1 binds to TLR4 or RAGE depending on its redox
state causing induction of innate immune responses (Janko
et al. 2014). Specifically, the Cys106 thiol/Cys23-Cys45 di-
sulfide form of HMGB1 acts at TLR4 while the fully reduced
form of HMGB1 is active at the RAGE receptor (Venereau
et al. 2012; Yang et al. 2012). Ethanol has been found to cause
nuclear translocation of HMGB1 through an epigenetic pro-
cess leading to cellular release in ex vivo slice culture (Zou
and Crews 2014). Expression of HMGB1 is increased in the
prefrontal cortex of postmortem human alcoholics and adult
rats following adolescent binge ethanol exposure (Crews et al.
2013; Vetreno and Crews 2012; Vetreno et al. 2013). In addi-
tion to direct receptor binding, extracellular HMGB1 can form
heterodimers with a number of molecules, including
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lipoglycans, endotoxin, cytokines (e.g., IL-1β), and nucleic
acids (e.g., microRNAs) (Bianchi 2009; Hreggvidsdottir
et al. 2009), resulting in increased potency of immune re-
sponses. Further, HMGB1 is necessary for the induction of
immune responses by endosome nucleic acid-binding TLRs
(i.e., TLR3, TLR7, and TLR9) (Yanai et al. 2009), although
the mechanism remains to be fully elucidated. Thus, alcohol-
induced release of HMGB1 might activate multiple TLRs
contributing to innate immune induction in brain.
In addition to HMGB1-TLR signaling pathways, ethanol
also modulates innate immune function through the release of
microRNAs (miRNAs), which are small, non-coding RNAs
(∼22 nucleotides) that regulate innate immunity (Thounaojam
et al. 2013). At present, miRNAs are thought to regulate innate
immunity through two processes that involve (1) the stabili-
zation of target mRNAs in the cytosol (Ambros 2004; Bartel
2004; Czech and Hannon 2011) and (2) extracellular release
of miRNAs (Ambros 2004; Bartel 2004; Czech and Hannon
2011). Previous studies have found that upregulation of
miRNAs is associated with psychiatric disorders (O’Connor
et al. 2016) and addiction (Dreyer 2010), although the precise
mechanism and impact on innate immune signaling are uncer-
tain. In the extracellular milieu, miRNAs are either bound to
lipoprotein chaperones or encapsulated in extracellular vesi-
cles (EVs) that can be endocytosed by neighboring cells,
thereby modulating their function. Ethanol exposure has been
found to alter miRNA expression in the brain. Encapsulated
miRNAs from ethanol-treated monocytes were found to mod-
ulate the activation state of naïve monocytes (Saha et al.
2016). Further, alcohol alters the expression profile of multi-
ple miRNAs in the frontal cortex of postmortem human alco-
holics and mice (Lewohl et al. 2011; Nunez and Mayfield
2012; Nunez et al. 2013). Interestingly, the miRNAs let-7
and miR-21 were recently identified as endogenous
endosomal TLR7 agonists (Lehmann et al. 2012;
Yelamanchili et al. 2015), and our laboratory found that etha-
nol potentiates TLR7-mediated innate immune induction
through the release of let-7 in microvesicles (Coleman et al.
2017). The miRNA miR-155 is also found in vesicles and
promotes TLR4-associated innate immune responses follow-
ing chronic ethanol exposure (Lippai et al. 2013a). Although
poorly understood at present, the release of miRNAs is an
additional mechanism through which ethanol activates TLRs
and the innate immune system, thereby contributing to the
stages of addiction.
Animal studies provide compelling evidence that the innate
immune system modulates alcohol consumptive behaviors.
Analysis of genetically paired rats and mice reveals that high
ethanol-drinking animals evidenced higher levels of NF-κB
and other proinflammatory genes relative to their low-
drinking litter mates (Mulligan et al. 2006). Indeed, expres-
sion of β2-microglobulin, a NF-κB target gene involved in
immune signaling (Pahl 1999), was elevated in high ethanol-
preferring brain transcriptomes (Mulligan et al. 2006). Studies
in transgenic mouse lines provide further support for the hy-
pothesis that the innate immune system regulates ethanol-
drinking behaviors. Across multiple ethanol-drinking para-
digms, transgenicmice with deletion of a single immune gene,
such as CD14 and IL-6, consumed significantly less ethanol
than matched wild-type controls (Blednov et al. 2005b, 2012).
Further, Blednov and colleagues (Blednov et al. 2011) found
that a single dose of LPS, the prototypical TLR4 agonist,
Fig. 4 Simplified schematic depicting mechanisms of alcohol-induced
alterations to brain plasticity. Alcohol binge drinking and abuse increases
expression of the endogenous innate immune receptor agonist high-
mobility group box 1 (HMGB1) leading to activation of the
transcription factor nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB) and subsequent induction of proinflammatory
cytokines and oxidases (Crews et al. 2013; Qin and Crews 2012a; Vetreno
and Crews 2012, 2015; Vetreno et al. 2016). This also leads to increased
expression of toll-like receptors (TLRs) and the receptor for advanced
glycation end-products (RAGE) (Crews et al. 2013; Vetreno and Crews
2012, 2015; Vetreno et al. 2013), which are receptors for HMGB1.
Activation of this signaling pathways leads to the establishment of
positive loops of amplification that persist during abstinence from
alcohol (Crews and Vetreno 2016) and alter synapse formation through
increased expression of thrombospondins (Risher et al. 2015) and
alterations in extracellular matrix proteins (Coleman et al. 2014).
Concomitantly, innate immune induction causes epigenetic
modifications that induce further release of HMGB1 (Zou and Crews
2014) that contribute to positive loops of amplification as well as
alterations in synaptic plasticity molecules (Pandey et al. 2015;
Sakharkar et al. 2016) that contribute to alterations in cognitive and
emotive functioning. Innate immune driven epigenetic modifications
might also lead to microglial alterations resulting in the reprogramming
of the innate immune system. Innate immune induction also causes
neurodegeneration (Braun and Crews 2000; Crews et al. 2000) and the
loss of neuron-specific cell populations (Boutros et al. 2015; Vetreno et al.
2014; Vetreno and Crews 2015; Vetreno et al. 2016) that might also
contribute to the dysfunctional cognitive and affective states observed
in addiction (Crews and Vetreno 2016)
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produced a delayed but long-lasting increase of ethanol self-
administration in mice. Similarly, site-specific microinjections
of a GABAAα2 small interfering RNA (siRNA) vector into
the central nucleus of the amygdala of alcohol-preferring rats
diminished binge drinking, which was associated with reduced
expression of TLR4 (Liu et al. 2011a). As GABAAα2
receptors are located on neurons, these data suggest that
involvement of TLR4 in binge drinking is at least partially
mediated by neurons. Indeed, both postmortem human and
rodent studies find that TLR2–TLR4, RAGE, and HMGB1
are expressed on neurons (Crews et al. 2013; Vetreno and
Crews 2012; Vetreno et al. 2013). Thus, there is accumulating
data for a neuromodulatory role of the innate immune system
in driving alcohol preference and consumption.
The frontal cortex mediates executive functions, including
motivation, planning and goal setting, and behavioral flexibil-
ity. In non-alcoholic social drinking humans, the heaviest
binge drinkers report more negative mood and perform worse
on executive functioning tasks (Townshend and Duka 2003;
Weissenborn and Duka 2003), suggesting that diminished
frontal cortical function occurs with binge drinking. In astro-
cytes, ethanol causes NF-κB transcription and downstream
induction of proinflammatory innate immune genes (Pascual
et al. 2007; Zou and Crews 2006, 2010) as well as a loss of
astrocyte glutamate transport (Zou and Crews 2005). Elevated
levels of extracellular glutamate result in increased neuronal
excitation, microglial activation, and excitotoxicity (Ward
et al. 2009; Zou and Crews 2006). In the frontal cortex,
ethanol-induced glutamate excitotoxicity results in increased
caspase-3 and COX-2 expressions that require TLR4 signal-
ing (Alfonso-Loeches et al. 2010; Knapp and Crews 1999).
Similar glutamate hyperexcitability also occurs in the
stimulant-addicted brain (Reissner and Kalivas 2010).
Activation of the innate immune system reduces glutamate
transporters, causing hyperexcitability that reduces frontal
cortical executive function, thereby contributing to the neuro-
biology of addiction (Crews et al. 2006a, 2011). Indeed, fron-
tal cortical dysfunction is common in the alcoholic brain
(Crews and Boettiger 2009) and is manifest in impulsivity
and impaired behavioral flexibility. In preclinical models, re-
versal learning tasks are used to assess frontal cortical func-
tion. Reversal learning provides a measure of behavioral flex-
ibility, which refers to the animals’ ability to adopt a new
behavioral response as a consequence of a shift in task de-
mands. Typically, impairments in reversal learning are associ-
atedwith increased perseveration of previously learned behav-
iors or the inability to break previously learned responses.
Studies from our laboratory have consistently revealed persis-
tent reversal learning deficits in adult rats following binge
ethanol exposure (Obernier et al. 2002c) as well as in adult
rats and mice following AIE treatments (Coleman et al. 2011;
Vetreno and Crews 2012). Interestingly, we found that mea-
sures of reversal learning and perseveration were correlated
with expression of TLRs, RAGE, and HMGB1 in the adult
prefrontal cortex following AIE (Vetreno and Crews 2012;
Vetreno et al. 2013) (see Fig. 5a). Additionally, deficits in
reversal learning are observed in rats that self-administer co-
caine or are exposed to passive cocaine injections (Calu et al.
2007; Schoenbaum et al. 2004), suggesting that behavioral
flexibil i ty deficits are common across addiction.
Involvement of the frontal cortex in reversal learning is further
supported by lesion-induced reversal learning deficits that are
similar in nature to chronic drug abuse-induced dysfunction
(Schoenbaum et al. 2006). Adolescent binge drinking is asso-
ciated with increased impulsivity (White et al. 2011) and risky
decision-making (Goudriaan et al. 2007). In preclinical
models, risk-based decision-making is assessed using the
probability-discounting task, in which rats must select either
a small reward (single food pellet) that is always delivered
(i.e., safe reward) or a large reward (four food pellets) that is
delivered with decreasing frequency (i.e., risky choice) across
trials. Elegant studies by Markou and colleagues (Boutros
et al. 2015) investigated risk-based decision-making in rats
using a probability-discounting task, in which rats must select
either a small reward (single food pellet) that is always deliv-
ered (i.e., safe reward) or a large reward (four food pellets) that
is delivered with decreased frequency (i.e., risky choice)
across trials. Control animals switched from the high-reward
level when more responses were required, reducing pellets,
whereas AIE-treated animals demonstrated an increased pref-
erence for the risky large reward, even when many more re-
sponses were required. This suggests that AIE increased adult
risky decisions (Boutros et al. 2015). Interestingly, increased
risky decision-making was negatively correlated with expres-
sion of choline acetyltransferase, a marker of cholinergic neu-
rons, in the basal forebrain, also reduced by AIE (see Fig. 5b).
Basal forebrain cholinergic neurons provide acetylcholine in-
puts to the frontal cortex, which are important modulators of
frontal cortical executive function (Baxter and Chiba 1999)
and impulsivity (Sarter and Paolone 2011). Treatment of rats
with LPS, the TLR4 agonist, causes a reduction of cholinergic
neurons similar to the effects of AIE on cholinergic popula-
tions in adulthood. These data implicate innate immune acti-
vation through TLR4 in the loss of specific neuron popula-
tions that might contribute to behavioral deficits commonly
observed in addiction. Taken together, considerable evidence
is emerging that supports a role for HMGB1/TLR4 signaling,
innate immune gene induction, and epigenetic alterations as
culminating in the neurobiology of addiction (Crews et al.
2011; Cui et al. 2015; Vetreno and Crews 2014).
Addiction, stress, and innate immune signaling
Cycles of exposure to drugs of abuse and stress interact, con-
tributing to a progressive sequence of stages leading to
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addiction (Volkow et al. 2016). Both drugs of abuse and stress
activate innate immune proinflammatory responses. Stress-
induced innate immune responses can have beneficial or mal-
adaptive consequences on brain function. Physical stressors,
such as injury and infection, induce proinflammatory cyto-
kines and other signaling molecules that trigger adaptive be-
havioral changes known as Bsickness behavior.^ Sickness be-
haviors, which include social withdrawal, decreased activity,
somnolence/sleepiness, and anhedonia, help facilitate energy
conservation and recovery from illness (Dantzer et al. 2008).
Interestingly, even psychological stressors (e.g., social stress)
can induce inflammatory responses (Steptoe et al. 2007). The
adaptive response of sickness behavior to acute stress and
inflammation is presumably beneficial; however, prolonged
or chronic exposure to stress and inflammation can become
maladaptive, leading to neuropsychiatric disease, such as de-
pression. Indeed, the similarities between sickness behavior
and depression are well known (Maes et al. 2012). Chronic
innate immune activation following prolonged alcohol and
drug abuse likely results in similar psychopathologies. Thus,
persistent innate immune induction caused by chronic
alcoholism might lead to maladaptive sickness behavior that
manifests as cognitive and emotive dysfunctions.
Recent studies find that stress and alcohol contribute to
inflammation through a similar mechanism of increased intes-
tinal permeability. Stress causes intestinal permeability and
bacterial translocation from the gut lumen (Garate et al.
2013). In response to the leaked bacteria, the peripheral im-
mune systemmounts a proinflammatory immune response. At
binge levels, alcohol (i.e., >2 g/kg; Ferrier et al. 2006) also
causes disruption of gut tight junctions, allowing for the trans-
location of gut bacteria into the periphery (Adachi et al. 1995).
The bacteria enter portal circulation leading to inflammation
of the liver and release of proinflammatory cytokines into
systemic circulation (Crews and Vetreno 2014; Mayfield
et al. 2013) (see Fig. 6). This has also been observed in
humans, with increased bacterial endotoxin and 16S RNA
after alcohol (Bala et al. 2014). The peripheral inflammatory
response can then impact the brain and behavior through sev-
eral routes (Critchley and Harrison 2013; Miller and Raison
2016). Systemic changes in cytokines, such as IL-1β, activate
IL-1 receptors located on the vagus nerve (Ek et al. 1998).
Fig. 5 Adolescent intermittent ethanol (AIE) treatment impairs reversal
learning and increases risky decision-making in adulthood. a From
postnatal day (P)25 to P55, AIE-treated male Wistar rats received a single
daily intragastric (i.g.) dose of ethanol (5.0 g/kg, 20% ethanol, w/v)
on a 2-day on/off schedule, and CON subjects received comparable
volumes of water as previously described (Vetreno and Crews 2012).
Following a 25-day abstinence period, spatial and reversal learning
were assessed on the Barnes maze. While AIE treatment did not impair
spatial learning, reversal learning, which provides a measure of
behavioral flexibility, was impaired in adulthood as evidenced by
increased latency to the reversal goal and increased perseveration.
Following behavioral testing, brain tissue was collected and tissue
stained for innate immune markers. Expression of toll-like receptor 4
(TLR4) was positive correlated with latency to the reversal goal,
indicating that innate immune induction by AIE contributes to deficits
in adult deficits in behavioral flexibility. Adopted from Vetreno and
Crews (2012). Data are presented as mean ± SEM. *p < 0.05. b From
P28 to P53, male Wistar rats received three daily i.g. doses of ethanol
(5.0 g/kg, 25% ethanol, w/v) on a 2-day on/off schedule, and CON
subjects received comparable volumes of water. Following an abstinent
period on P63, training and testing were performed on the probability-
discounting task. Prior AIE treatment significantly increased risky
responses at reducing reward probabilities, relative to CON subjects.
Expression of choline acetyltransferase (ChAT), a marker of cholinergic
neurons, was reduced in the basal forebrain of adult AIE-treated animals
that was negatively correlated with probability-discounting behavior.
Adopted from Markou and colleagues (Boutros et al. 2015). Data are
presented as mean ± SEM. *p < 0.05
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Vagal activation is transmitted to neural centers within the
brain to promote the induction of sickness behaviors.
Indeed, vagotomy reduces the sickness behavioral response
to a peripheral injection of LPS, the TLR4 agonist (Bluthe
et al. 1994). Secondly, peripheral cytokines can influence
brain and behavior through transport in the blood.
Proinflammatory cytokines in the blood can diffuse through
permeable regions of the blood-brain barrier (BBB), such as
the circumventricular organs, or be transported across the
blood-brain barrier (Banks and Erickson 2010; Qin et al.
2007). TNFα transporters on the BBB are essential for sys-
temic inflammation to cause brain inflammation (Qin et al.
2007). Similarly, in humans, circulating TNFα alters avail-
ability of the brain serotonin transporter (Krishnadas et al.
2016) and activation of immune signaling following vaccina-
tion causes confusion, fatigue, and loss of motivation
(Harrison et al. 2009b). Fatigue following experimental in-
flammation in humans induces altered cortical metabolism
and microstructure of the insular cortex (Harrison et al.
2015). Activated immune cells such as monocytes can be
trafficked into the brain; however, this mechanism has been
questioned with recent discoveries on microglial origination
(Ginhoux et al. 2013). Once activated in brain, the innate
immune response persists (Qin et al. 2008), thereby contrib-
uting to the neurobiology of addiction through the induction
of alcohol consumptive behaviors as well as cognitive and
emotive dysfunctions.
Innate immunity may contribute to progressive
stages of addiction
Current theories conceptualize addiction as encompassing a
three-stage cycle that includes (1) binge/intoxication, (2)
withdrawal/negative affect, and (3) preoccupation/craving
(Koob and Volkow 2010) that contribute to the maintenance
of substance use disorders. Accumulating evidence suggests
that the innate immune system plays a role in each stage of the
addiction cycle. With regards to the binge/intoxication stage,
blockade of cocaine-induced upregulation of IL-1β in the
ventral tegmental area (VTA) with the (+)-isomer of naloxone,
a TLR4 antagonist, prevented the subsequent increase of do-
pamine release in the nucleus accumbens and diminished co-
caine self-administration (Northcutt et al. 2015). Interestingly,
this effect may be mediated in part by TLR4 signaling in
microglia as treatment with minocycline, a microglial inhibi-
tor, blocked cocaine-induced, conditioned place preference,
supporting a role for the innate immune system in the reward-
ing effects of drugs of abuse. Similarly, self-administration of
ethanol in the drinking in the dark paradigm in mice has been
shown to increase expression of IL-1β in the basolateral
amygdala. Injections of IL-1-ra, an IL-1 receptor antagonist,
into the basolateral amygdala reduced ethanol self-
administration in these animals (Marshall et al. 2016).
Further, delivery of siRNAs for TLR4 or MCP-1 into either
the VTA or central nucleus of the amygdala blunted ethanol
Fig. 6 Mechanisms of stress- and ethanol-induced innate immune
activation. Alcohol and stress activate the peripheral and central
immune systems in multiple ways. Alcohol and stress cause
microbiome dysbiosis and disrupt gut tight junctions, leading to
permeability of the gut and release of bacteria and endotoxin that enter
portal circulation-inducing inflammatory responses in the liver. The
consequent release of inflammatory cytokines from the liver activates
the innate immune system in brain through direct transport via cytokine
receptors and activation of the vagus nerve. Stress and alcohol exposure
leads to innate immune activation in brain that induces sickness-like
behaviors that contribute to the stages of addiction. These pathways of
ethanol- and stress-induced activation of HMGB1-LTR signaling likely
contribute to the persistent and progressive stages of addiction
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self-administration in alcohol-preferring rats (June et al.
2015). Across multiple ethanol-drinking paradigms, transgen-
ic mice with deletion of a single immune gene, such as CD14
and IL-6, consumed significantly less ethanol than matched
wild-type controls (Blednov et al. 2005a, 2012). Conversely,
stimulation of the innate immune system has been found to
elicit ethanol consumptive behaviors. Indeed, systemic admin-
istration of LPS to adult mice produced a delayed but long-
lasting increase in ethanol self-administration in mice
(Blednov et al. 2011). Similarly, ventricular infusions of
MCP-1 increase ethanol self-administration in rats (Valenta
and Gonzales 2016). Together, these data provide evidence
that the innate immune system, including TLRs, is involved
in the binge/intoxication stage of addiction.
There is also evidence implicating innate immune activa-
tion in the withdrawal/negative affect stage of addiction.
Substance abuse is associated with the development of nega-
tive affective states, such as anxiety and dysphoria (Koob and
Le Moal 2005), which are commonly observed during the
withdrawal stage of addiction. Indeed, the negative states as-
sociated with withdrawal are likely a driving force behind
continued substance use, thereby contributing to cycles of
abuse that might lead to dependence. Evidence indicates that
it is during ethanol withdrawal that proinflammatory cytokine
induction increases in brain. Freeman et al. (2012) found that
expressions of MCP-1, NOS-2, TNFα, and the TNFα recep-
tor are increased in the central nucleus of the amygdala fol-
lowing 48 h of withdrawal. Administration of LPS and cyto-
kines sensitize the anxiety- and depressive-like behaviors as-
sociated with ethanol withdrawal (Breese et al. 2008).
Knockout of TLR4 protects against ethanol withdrawal asso-
ciated anxiety-like behavior and memory impairment (Pascual
et al. 2011). These data implicate TLR4 and the innate im-
mune system in ethanol withdrawal and the development of
negative affect, although the mechanism remains to be fully
determined. A probable point of convergence of withdrawal-
induced innate immune upregulation and negative affect is
hippocampal neurogenesis. Hippocampal neurogenesis is in-
volved in regulation of mood and affective states (Malberg
et al. 2000), and ethanol and LPS treatments reduce
neurogenesis (see, e.g., Vetreno and Crews 2015).
Importantly, reductions in hippocampal neurogenesis are ob-
served during ethanol withdrawal that was associated with
increased depression-like behavior on the forced swim test
in mice (Stevenson et al. 2009). Further, the effects of ethanol
withdrawal were prevented by anti-depressant treatment.
Stress causes induction of innate immune signaling in brain
and mounting evidence indicates that immune activation can
lead to alterations in affective states. As mentioned in the
previous section, stress sensitizes microglia to inflammation
in an HMGB1-dependent manner (Weber et al. 2015), and
chronic stress activates microglia in multiple brain regions
(Tynan et al. 2010) and causes depression-like behavior.
Administration of microglial-modulating agents can block
the development of depression-like behavior in rodents
(Kreisel et al. 2014). Similarly, human studies also provide
support for the involvement of stress and inflammation in
affective disorders. Patients receiving systemic interferon-α
for the treatment of hepatitis C can develop depression-like
symptoms in the absence of a prior history of depression
(Bonaccorso et al. 2002). Individuals with increased plasma
levels of C-reactive protein (CRP), an acute phase marker of
inflammation, are at greater risk for the development of de-
pression (Young et al. 2014), and increased plasma level of
CRP in adolescents is predictive of addiction later in life
(Costello et al. 2013). Further, peripheral inflammation, which
can increase innate immune signaling in brain, has been found
to contribute to negative affect (Harrison et al. 2014). Human
PET neuroimaging studies also find that expression levels of
translocator protein (18 kDa), a marker of reactive microglia,
are increased in the prefrontal cortex, insula, and anterior cin-
gulate cortex of individuals during a major depressive episode
(Setiawan et al. 2015). In depressed individuals who commit
suicide, expression levels of microglial markers (i.e., Iba-1
and CD45) and the proinflammatory cytokine MCP-1 are in-
creased in the cingulate cortex (Torres-Platas et al. 2014).
These studies suggest that systemic inflammation leads to
increased innate immune signaling in brain, contributing to
the development of affective disorders.
Evidence supports an involvement of the innate immune
system in affective disorders, but the mechanism remains to be
elucidated fully. The literature provides evidence that a poten-
tial mechanism for innate immune involvement in the devel-
opment of affective disorders involves alterations in the activ-
ity of neural circuitry that modulates affect. Administration of
a typhoid vaccine was found to increase circulating levels of
the proinflammatory cytokine IL-6 and significantly reduce
mood (Harrison et al. 2009a). Interestingly, functional mag-
netic resonance imaging in these same participants revealed
that the inflammation-induced reduction in mood was corre-
lated with increased activity in the subgenual anterior cingu-
late cortex, a region implicated in the etiology of depression,
and reduced connectivity of this region with the amygdala,
prefrontal cortex, and nucleus accumbens (Harrison et al.
2009a). Studies also find that a variety of cytokine receptors,
such as those for TNFα, IL-1β, IL-6, and the interferons, are
expressed on neurons (Khairova et al. 2009), suggesting that
cytokines act directly on neurons to influence their activity.
Indeed, innate immune induction can reduce populations of
serotonin (5-HT)-producing neurons in the raphe nucleus, and
the serotonergic system has also been implicated in the etiol-
ogy of affective disorders (Kelley et al. 2011). We found that
AIE treatment persistently reduces populations of 5-HT-
immunopositive neurons in the adult raphe nucleus, an effect
that was mimicked by treatment with the TLR4 agonist LPS.
Inflammation also increases activity of indolamine 2,3-
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dioxygenase (IDO), an enzyme that converts tryptophan (a
precursor of 5-HT) to kynurenine, thereby reducing the syn-
thesis of 5-HT (Wichers and Maes 2004). Interestingly,
kynurenine has also been shown to induce depression-like
behavior, and pharmacological inhibition of IDO blocks
microglial activation and the development of depression-
like behavior (O’Connor et al. 2009). Induction of innate
immunity can also disrupt hippocampal neurogenesis, the
process whereby new neurons are continuously added to
the existing hippocampal neurocircuitry. Although heavily
implicated in learning and memory processes, neurogenesis
is also involved in mood and affective states (Malberg
et al. 2000). Further, the ability of anti-depressants to al-
leviate depression-like behavior appears to be dependent
upon hippocampal neurogenesis (Santarelli et al. 2003).
Both inflammation (Ryan and Nolan 2016) and chronic
stress (Kreisel et al. 2014) reduce neurogenesis and cause
depression-like behavior. Further, stress induces IL-1β in
the hippocampus, which decreases neurogenesis and con-
tributes to depression, while inhibition of IL-1β blocks
stress-induced decreases in neurogenesis and depression-
like behavior (Koo and Duman 2008). While these data
provide compelling evidence that the innate immune sys-
tem modulates affect, the mechanism likely involves alter-
ations to discrete nuclei as well as modifications to con-
nectivity between regions. Together, these data implicate
the TLR/innate immune system in the withdrawal/
negative affect stage of addiction.
Evidence also implicates the TLR-innate immune system
in the third stage of addiction involving preoccupation with
drug taking and craving, which is associatedwith a heightened
likelihood of relapse. Plasma levels of the proinflammatory
cytokines IL-8 and IL-1β were positively correlated with in-
dices of alcohol craving in human alcohol-dependent subjects
(Leclercq et al. 2014). As mentioned above, stress (Madrigal
et al. 2002, 2003) and drugs of abuse (Ang et al. 2001b; Crews
and Vetreno 2014, 2016; Vetreno and Crews 2014) activate
and sensitize (Frank et al. 2007; Qin and Crews 2012a) the
innate immune system in brain. The innate immune system
modulates alcohol consumptive behaviors (Blednov et al.
2005b, 2011; 2012; Liu et al. 2011b), and stressful events
during abstinence might interact with the primed innate im-
mune system leading to the craving to consume alcohol and
other drugs of abuse. Treatment of abstinent human alcoholics
with naltrexone, a TLR4 antagonist, reduced subjective
reporting of craving (Nava et al. 2006). Similarly, treatment
with the (+)-isomer of naltrexone, which is inactive at the
opioid receptor, blocked heroin-seeking behavior in depen-
dent rats (Theberge et al. 2013). Thus, TLR4 and innate im-
mune signaling molecules contribute to the preoccupation/
craving stage of addiction. Taken together, the evidence sug-
gests that activation of the innate immune system in brain
contributes to each stage of addiction.
Summary
The discovery that innate immune mechanisms contribute to
the neurobiology of addiction provides a novel approach for
the treatment of alcohol use disorders. While innate immune
activation contributes to alcohol consumptive behaviors, it
also contributes to alcohol-induced neurodegeneration
(Crews et al. 2004, 2006b; Obernier et al. 2002a, b; Qin
et al. 2013). It is not clear how innate immune signaling alters
specific neurocircuits. Innate immune signaling involves pos-
itive loops since cytokine and TLRs converge on NF-κB in-
ducing additional cytokines and their receptors. However,
HMGB1 and TLR activation could be the initial key signaling
event. The current studies find innate immune signaling in
most brain diseases with little evidence distinguishing activa-
tion in mental diseases and neurodegenerative diseases (e.g.,
addiction, Alzheimer’s disease, and depression). It remains to
be determined whether therapies that target the innate immune
system would be of benefit for the prevention of the progres-
sion to addiction and if these therapies could improve recov-
ery from alcohol use disorders. Some studies have found that
systemic anti-inflammatory agents reduce symptoms, but little
is known on how brain inflammatory gene expression is im-
pacted. Indeed, neurodegeneration would likely not be re-
versed, although interventions might allow for the recovery
of normal synaptic function. Minocycline, a tetracycline anti-
biotic and microglial inhibitor (Plane et al. 2010), prevents
ethanol induced-microglial activation and reduces alcohol
self-administration (Agrawal et al. 2011; Qin and Crews
2012a).While studies are currently underway, further research
is clearly warranted to explore the therapeutic potential of
immune interventions in the treatment of alcohol use
disorders.
Acknowledgements This work was supported in part by funding from
the National Institutes of Health, National Institute on Alcoholism and
Alcohol Abuse through the Neurobiology of Adolescent Drinking in
Adulthood (NADIA) consortium (AA020024, AA020023), the Bowles
Center for Alcohol Studies (AA011605), and the U54 collaborative part-
nership between NCCU andUNC (AA019767). The authors thankKathy
Neal for the help with preparation and submission of this manuscript.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG (1995)
Antibiotics prevent liver injury in rats following long-term exposure
to ethanol. Gastroenterology 108:218–224
Psychopharmacology (2017) 234:1483–1498 1493
Agrawal RG, Hewetson A, George CM, Syapin PJ, Bergeson SE (2011)
Minocycline reduces ethanol drinking. Brain Behav Immun
25(Suppl 1):S165–S169
Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I,
Guerri C (2010) Pivotal role of TLR4 receptors in alcohol-induced
neuroinflammation and brain damage. J Neurosci Off J Soc
Neurosci 30:8285–8295
Ambros V (2004) The functions of animal microRNAs. Nature 431:350–
355
Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ
(2001a) Induction of nuclear factor-kappaB in nucleus accumbens
by chronic cocaine administration. J Neurochem 79:221–224
Arancio O, Zhang HP, Chen X, Lin C, Trinchese F, Puzzo D, Liu S,
Hegde A, Yan SF, Stern A, Luddy JS, Lue LF, Walker DG, Roher
A, Buttini M, Mucke L, Li W, Schmidt AM, Kindy M, Hyslop PA,
Stern DM, Du Yan SS (2004) RAGE potentiates Abeta-induced
perturbation of neuronal function in transgenic mice. EMBO J 23:
4096–4105
Bala S, Marcos M, Gattu A, Catalano D, Szabo G (2014) Acute binge
drinking increases serum endotoxin and bacterial DNA levels in
healthy individuals. PLoS One 9:e96864
Banks WA, Erickson MA (2010) The blood-brain barrier and immune
function and dysfunction. Neurobiol Dis 37:26–32
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and
function. Cell 116:281–297
Baxter MG, Chiba AA (1999) Cognitive functions of the basal forebrain.
Curr Opin Neurobiol 9:178–183
Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know
about danger. J Leukoc Biol 81:1–5
Bianchi ME (2009) HMGB1 loves company. J Leukoc Biol 86:573–576
Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D,
Ferstl R, von EynattenM,Wendt T, Rudofsky G, JoswigM,Morcos
M, SchwaningerM,McEwen B, KirschbaumC, Nawroth PP (2003)
A mechanism converting psychosocial stress into mononuclear cell
activation. Proc Natl Acad Sci U S A 100:1920–1925
Blednov YA, Bergeson SE, Walker D, Ferreira VM, Kuziel WA,
Harris RA (2005a) Perturbation of chemokine networks by gene
deletion alters the reinforcing actions of ethanol. Behav Brain Res
165:110–125
Blednov YA, Bergeson SE, Walker D, Ferreira VM, Kuziel WA,
Harris RA (2005b) Perturbation of chemokine networks by gene
deletion alters the reinforcing actions of ethanol. Behav Brain Res
165:110–125
Blednov YA, Benavidez JM, Geil C, Perra S, Morikawa H, Harris RA
(2011) Activation of inflammatory signaling by lipopolysaccharide
produces a prolonged increase of voluntary alcohol intake in mice.
Brain Behav Immun 25(Suppl 1):S92–S105
Blednov YA, Ponomarev I, Geil C, Bergeson S, Koob GF, Harris RA
(2012) Neuroimmune regulation of alcohol consumption: behavior-
al validation of genes obtained from genomic studies. Addict Biol
17:108–120
Bluthe RM, Walter V, Parnet P, Laye S, Lestage J, Verrier D, Poole S,
Stenning BE, Kelley KW, Dantzer R (1994) Lipopolysaccharide
induces sickness behaviour in rats by a vagal mediated mechanism.
C R Acad Sci III 317:499–503
Bonaccorso S, Marino V, Biondi M, Grimaldi F, Ippoliti F, Maes M
(2002) Depression induced by treatment with interferon-alpha in
patients affected by hepatitis C virus. J Affect Disord 72:237–241
Boutros N, Semenova S, LiuW, Crews FT, Markou A (2014) Adolescent
intermittent ethanol exposure is associated with increased risky
choice and decreased dopaminergic and cholinergic neuron markers
in adult rats. Int J Neuropsychopharmacol 18
Boutros N, Semenova S, LiuW, Crews FT, Markou A (2015) Adolescent
intermittent ethanol exposure is associated with increased risky
choice and decreased dopaminergic and cholinergic neuron markers
in adult rats. Int J Neuropsychopharmacol 18
Boutros N, Der-Avakian A, Semenova S, Lee S, Markou A (2016) Risky
choice and brain CRF after adolescent ethanol vapor exposure and
social stress in adulthood. Behav Brain Res 311:160–166
Braun CJ, Crews FT (2000) Binge ethanol treatment causes greater neu-
rodegeneration in alcohol preferring (P) rats as compared to non-
alcohol preferring (NP) rats. Alcohol Clin Exp Res 24:65A
Breese GR, Knapp DJ, Overstreet DH, Navarro M, Wills TA, Angel RA
(2008) Repeated lipopolysaccharide (LPS) or cytokine treatments
sensitize ethanol withdrawal-induced anxiety-like behavior.
Neuropsychopharmacology 33:867–876
Brites D, Fernandes A (2015) Neuroinflammation and depression: mi-
croglia activation, extracellular microvesicles and microRNA dys-
regulation. Front Cell Neurosci 9:476
Brubaker SW, Bonham KS, Zanoni I, Kagan JC (2015) Innate immune
pattern recognition: a cell biological perspective. Annu Rev
Immunol 33:257–290
Calu DJ, Roesch MR, Stalnaker TA, Schoenbaum G (2007) Associative
encoding in posterior piriform cortex during odor discrimination and
reversal learning. Cereb Cortex 17:1342–1349
Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW,
Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA (2005)
Thrombospondins are astrocyte-secreted proteins that promote
CNS synaptogenesis. Cell 120:421–433
Coleman LG Jr, He J, Lee J, Styner M, Crews FT (2011) Adolescent
binge drinking alters adult brain neurotransmitter gene expression,
behavior, brain regional volumes, and neurochemistry in mice.
Alcohol Clin Exp Res 35:671–688
Coleman LG Jr, Liu W, Oguz I, Styner M, Crews FT (2014) Adolescent
binge ethanol treatment alters adult brain regional volumes, cortical
extracellular matrix protein and behavioral flexibility. Pharmacol
Biochem Behav 116:142–151
Coleman Jr LG, Zou J, Crews FT (2017) Microglial-derived miRNALet-
7 and HMGB1 contribute to ethanol-induced neurotoxicity via
TLR7. J Neuroinflammation
Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A
(2013) C-reactive protein and substance use disorders in adoles-
cence and early adulthood: a prospective analysis. Drug Alcohol
Depend 133:712–717
Crews FT, Boettiger CA (2009) Impulsivity, frontal lobes and risk for
addiction. Pharmacol Biochem Behav 93:237–247
Crews FT, Vetreno RP (2014) Neuroimmune basis of alcoholic brain
damage. Int Rev Neurobiol 118:315–357
Crews FT, Vetreno RP (2016) Mechanisms of neuroimmune gene induc-
tion in alcoholism. Psychopharmacology 233:1543–1557
Crews FT, Braun CJ, Hoplight B, Switzer RC 3rd, Knapp DJ (2000)
Binge ethanol consumption causes differential brain damage in
young adolescent rats compared with adult rats. Alcohol Clin Exp
Res 24:1712–1723
Crews FT, Collins MA, Dlugos C, Littleton J, Wilkins L, Neafsey EJ,
Pentney R, Snell LD, Tabakoff B, Zou J, Noronha A (2004)
Alcohol-induced neurodegeneration: when, where and why?
Alcohol Clin Exp Res 28:350–364
Crews F, Nixon K, Kim D, Joseph J, Shukitt-Hale B, Qin L, Zou J
(2006a) BHT blocks NF-kappaB activation and ethanol-induced
brain damage. Alcohol Clin Exp Res 30:1938–1949
Crews F, Nixon K, Kim D, Joseph J, Shukitt-Hale B, Qin L, Zou J
(2006b) BHT blocks NF-kappaB activation and ethanol-induced
brain damage. Alcohol Clin Exp Res 30:1938–1949
Crews FT, Zou J, Qin L (2011) Induction of innate immune genes in brain
create the neurobiology of addiction. Brain Behav Immun 25(Suppl
1):S4–S12
Crews FT, Qin L, Sheedy D, Vetreno RP, Zou J (2013) High mobility
group box 1/toll-like receptor danger signaling increases brain
neuroimmune activation in alcohol dependence. Biol Psychiatry
73:602–612
1494 Psychopharmacology (2017) 234:1483–1498
Crews FT, Vetreno RP, BroadwaterMA, RobinsonDL (2016) Adolescent
alcohol exposure persistently impacts adult neurobiology and be-
havior. Pharmacol Rev 68:1074–1109
Critchley HD, Harrison NA (2013) Visceral influences on brain and be-
havior. Neuron 77:624–638
Cui C, Noronha A, Warren KR, Koob GF, Sinha R, Thakkar M,
Matochik J, Crews FT, Chandler LJ, Pfefferbaum A, Becker
HC, Lovinger D, Everitt BJ, Egli M, Mandyam CD, Fein G,
Potenza MN, Harris RA, Grant KA, Roberto M, Meyerhoff DJ,
Sullivan EV (2015) Brain pathways to recovery from alcohol
dependence. Alcohol 49:435–452
Czech B, Hannon GJ (2011) Small RNA sorting: matchmaking for
Argonautes. Nat Rev Genet 12:19–31
Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008)
From inflammation to sickness and depression: when the immune
system subjugates the brain. Nat Rev Neurosci 9:46–56
Dreyer JL (2010) New insights into the roles of microRNAs in drug
addiction and neuroplasticity. Genome Med 2:92
EkM, KurosawaM, Lundeberg T, Ericsson A (1998) Activation of vagal
afferents after intravenous injection of interleukin-1beta: role of en-
dogenous prostaglandins. J Neurosci 18:9471–9479
Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D,Walker DG, Stern DM,
Schmidt AM, Chen JX, Yan SS (2010) RAGE-dependent signaling
in microglia contributes to neuroinflammation, Abeta accumulation,
and impaired learning/memory in a mouse model of Alzheimer’s
disease. FASEB J 24:1043–1055
Farina C, Aloisi F, Meinl E (2007) Astrocytes are active players in cere-
bral innate immunity. Trends Immunol 28:138–145
Fernandez-Lizarbe S, Montesinos J, Guerri C (2013) Ethanol induces
TLR4/TLR2 association, triggering an inflammatory response in
microglial cells. J Neurochem 126:261–273
Ferrier L, Berard F, Debrauwer L, Chabo C, Langella P, Bueno L,
Fioramonti J (2006) Impairment of the intestinal barrier by ethanol
involves enteric microflora and mast cell activation in rodents. Am J
Pathol 168:1148–1154
Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF (2007)
Microglia serve as a neuroimmune substrate for stress-induced po-
tentiation of CNS pro-inflammatory cytokine responses. Brain
Behav Immun 21:47–59
Frank MG, Weber MD, Watkins LR, Maier SF (2015) Stress sounds the
alarmin: the role of the danger-associated molecular pattern
HMGB1 in stress-induced neuroinflammatory priming. Brain
Behav Immun 48:1–7
Freeman K, BrureauA, Vadigepalli R, StaehleMM, BrureauMM, Gonye
GE, Hoek JB, Hooper DC, Schwaber JS (2012) Temporal changes
in innate immune signals in a rat model of alcohol withdrawal in
emotional and cardiorespiratory homeostatic nuclei. J
Neuroinflammation 9:97
Garate I, Garcia-Bueno B, Madrigal JL, Caso JR, Alou L, Gomez-Lus
ML, Mico JA, Leza JC (2013) Stress-induced neuroinflammation:
role of the toll-like receptor-4 pathway. Biol Psychiatry 73:32–43
Ginhoux F, Greter M, LeboeufM, Nandi S, See P, Gokhan S,Mehler MF,
Conway SJ, Ng LG, Stanley ER, Samokhvalov IM, Merad M
(2010) Fate mapping analysis reveals that adult microglia derive
from primitive macrophages. Science 330:841–845
Ginhoux F, Lim S, Hoeffel G, Low D, Huber T (2013) Origin and differ-
entiation of microglia. Front Cell Neurosci 7:45
Goudriaan AE, Grekin ER, Sher KJ (2007) Decision making and binge
drinking: a longitudinal study. Alcohol Clin Exp Res 31:928–938
Hanke ML, Kielian T (2011) Toll-like receptors in health and disease
in the brain: mechanisms and therapeutic potential. Clin Sci 121:
367–387
Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD
(2009a) Inflammation causes mood changes through alterations in
subgenual cingulate activity and mesolimbic connectivity. Biol
Psychiatry 66:407–414
Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Critchley HD
(2009b) Inflammation causes mood changes through alterations in
subgenual cingulate activity and mesolimbic connectivity. Biol
Psychiatry 66:407–414
Harrison NA, Doeller CF, Voon V, Burgess N, Critchley HD (2014)
Peripheral inflammation acutely impairs human spatial memory
via actions on medial temporal lobe glucose metabolism. Biol
Psychiatry 76:585–593
Harrison NA, Cooper E, Dowell NG, Keramida G, Voon V, Critchley
HD, Cercignani M (2015) Quantitative magnetization transfer im-
aging as a biomarker for effects of systemic inflammation on the
brain. Biol Psychiatry 78:49–57
He J, Crews FT (2008) IncreasedMCP-1 andmicroglia in various regions
of the human alcoholic brain. Exp Neurol 210:349–358
Hreggvidsdottir HS, Ostberg T, Wahamaa H, Schierbeck H, Aveberger
AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris
HE (2009) The alarmin HMGB1 acts in synergy with endogenous
and exogenous danger signals to promote inflammation. J Leukoc
Biol 86:655–662
Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao
TX, Slivka PF, Coats BD, Rezvani N, Wieseler J, Hughes TS,
Landgraf KE, Chan S, Fong S, Phipps S, Falke JJ, Leinwand LA,
Maier SF, Yin H, Rice KC, Watkins LR (2010) Evidence that opi-
oids may have toll-like receptor 4 and MD-2 effects. Brain Behav
Immun 24:83–95
Janko C, Filipovic M, Munoz LE, Schorn C, Schett G, Ivanovic-
Burmazovic I, Herrmann M (2014) Redox modulation of
HMGB1-related signaling. Antioxid Redox Signal 20:1075–1085
June HL, Liu J, Warnock KT, Bell KA, Balan I, Bollino D, Puche A,
Aurelian L (2015) CRF-amplified neuronal TLR4/MCP-1 signaling
regulates alcohol self-administration. Neuropsychopharmacology
40:1549–1559
Kelley KW, Dantzer, Robert (2011) Alcoholism and inflammation:
neuroimmunology of behavioral and mood disorders. Brain
Behav Immun
Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential
role for pro-inflammatory cytokines in regulating synaptic plastic-
ity in major depressive disorder. Int J Neuropsychopharmacol 12:
561–578
Knapp DJ, Crews FT (1999) Induction of cyclooxygenase-2 in brain
during acute and chronic ethanol treatment and ethanol withdrawal.
Alcohol Clin Exp Res 23:633–643
Koo JW, Duman RS (2008) IL-1beta is an essential mediator of the
antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci
U S A 105:751–756
Koob GF, Le Moal M (2005) Plasticity of reward neurocircuitry and the
Bdark side^ of drug addiction. Nat Neurosci 8:1442–1444
Koob GF, Volkow ND (2010) Neurocircuitry of addiction.
Neuropsychopharmacology 35:217–238
Kreisel T, Frank MG, Licht T, Reshef R, Ben-Menachem-Zidon O,
Baratta MV, Maier SF, Yirmiya R (2014) Dynamic microglial alter-
ations underlie stress-induced depressive-like behavior and sup-
pressed neurogenesis. Mol Psychiatry 19:699–709
Krishnadas R, Nicol A, Sassarini J, Puri N, BurdenAD, Leman J, Combet
E, Pimlott S, Hadley D, McInnes IB, Cavanagh J (2016) Circulating
tumour necrosis factor is highly correlated with brainstem serotonin
transporter availability in humans. Brain Behav Immun 51:29–38
Leclercq S, De Saeger C, Delzenne N, de Timary P, Starkel P (2014) Role
of inflammatory pathways, blood mononuclear cells, and gut-
derived bacterial products in alcohol dependence. Biol Psychiatry
76:725–733
Lehmann SM,Kruger C, Park B, DerkowK, Rosenberger K, Baumgart J,
Trimbuch T, Eom G, Hinz M, Kaul D, Habbel P, Kalin R, Franzoni
E, Rybak A, Nguyen D, Veh R, Ninnemann O, Peters O, Nitsch R,
Heppner FL, Golenbock D, Schott E, Ploegh HL, Wulczyn FG,
Lehnardt S (2012) An unconventional role for miRNA: let-7
Psychopharmacology (2017) 234:1483–1498 1495
activates toll-like receptor 7 and causes neurodegeneration. Nat
Neurosci 15:827–835
Lewohl JM, Nunez YO, Dodd PR, Tiwari GR, Harris RA, Mayfield RD
(2011) Up-regulation of microRNAs in brain of human alcoholics.
Alcohol Clin Exp Res 35:1928–1937
Lippai D, Bala S, Csak T, Kurt-Jones EA, Szabo G (2013a) Chronic
alcohol-induced microRNA-155 contributes to neuroinflammation
in a TLR4-dependent manner in mice. PLoS One 8:e70945
Lippai D, Bala S, Petrasek J, Csak T, Levin I, Kurt-Jones EA, Szabo G
(2013b) Alcohol-induced IL-1beta in the brain is mediated by
NLRP3/ASC inflammasome activation that amplifies neuroinflam-
mation. J Leukoc Biol 94:171–182
Liu J, Yang AR, Kelly T, Puche A, Esoga C, June HL Jr, Elnabawi A,
Merchenthaler I, Sieghart W, June HL Sr, Aurelian L (2011a) Binge
alcohol drinking is associated with GABAA alpha2-regulated toll-
like receptor 4 (TLR4) expression in the central amygdala. Proc Natl
Acad Sci U S A 108:4465–4470
Liu J, Yang AR, Kelly T, Puche A, Esoga C, June HL Jr, Elnabawi A,
Merchenthaler I, Sieghart W, June HL Sr, Aurelian L (2011b) Binge
alcohol drinking is associated with GABAA alpha2-regulated toll-
like receptor 4 (TLR4) expression in the central amygdala. Proc Natl
Acad Sci U S A 108:4465–4470
Maczurek A, Shanmugam K, Munch G (2008) Inflammation and the
redox-sensitive AGE-RAGE pathway as a therapeutic target in
Alzheimer’s disease. Ann N YAcad Sci 1126:147–151
Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Leza JC (2002) Stress-
induced increase in extracellular sucrose space in rats is mediated by
nitric oxide. Brain Res 938:87–91
Madrigal JL, Garcia-Bueno B, Moro MA, Lizasoain I, Lorenzo P, Leza
JC (2003) Relationship between cyclooxygenase-2 and nitric oxide
synthase-2 in rat cortex after stress. Eur J Neurosci 18:1701–1705
MaesM, Berk M, Goehler L, Song C, Anderson G, Galecki P, Leonard B
(2012) Depression and sickness behavior are Janus-faced responses
to shared inflammatory pathways. BMC Med 10:66
Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000) Chronic antidepres-
sant treatment increases neurogenesis in adult rat hippocampus. J
Neurosci 20:9104–9110
Markou A, Kosten TR, Koob GF (1998) Neurobiological similarities in
depression and drug dependence: a self-medication hypothesis.
Neuropsychopharmacology 18:135–174
Maroso M, Balosso S, Ravizza T, Liu J, Bianchi ME, Vezzani A (2011)
Interleukin-1 type 1 receptor/toll-like receptor signalling in epilepsy:
the importance of IL-1beta and high-mobility group box 1. J Intern
Med 270:319–326
Marshall SA, Casachahua JD, Rinker JA, Blose AK, Lysle DT, Thiele TE
(2016) IL-1 receptor signaling in the basolateral amygdala modu-
lates binge-like ethanol consumption in male C57BL/6J mice. Brain
Behav Immun 51:258–267
Mayfield J, Ferguson L, Harris RA (2013) Neuroimmune signaling: a key
component of alcohol abuse. Curr Opin Neurobiol 23:513–520
Mejia-Toiber J, Boutros N, Markou A, Semenova S (2014) Impulsive
choice and anxiety-like behavior in adult rats exposed to chronic
intermittent ethanol during adolescence and adulthood. Behav
Brain Res 266:19–28
Miller AH, Raison CL (2016) The role of inflammation in depression:
from evolutionary imperative to modern treatment target. Nat Rev
Immunol 16:22–34
Montesinos J, Pascual M, Rodriguez-Arias M, Minarro J, Guerri C
(2016) Involvement of TLR4 in the long-term epigenetic changes,
rewarding and anxiety effects induced by intermittent ethanol treat-
ment in adolescence. Brain Behav Immun 53:159–171
Mulligan MK, Ponomarev I, Hitzemann RJ, Belknap JK, Tabakoff
B, Harris RA, Crabbe JC, Blednov YA, Grahame NJ, Phillips
TJ, Finn DA, Hoffman PL, Iyer VR, Koob GF, Bergeson SE
(2006) Toward understanding the genetics of alcohol drinking
through transcriptome meta-analysis. Proc Natl Acad Sci U S
A 103:6368–6373
Nava F, Premi S, Manzato E, Lucchini A (2006) Comparing treatments of
alcoholism on craving and biochemical measures of alcohol con-
sumption. J Psychoactive Drugs 38:211–217
Northcutt AL, Hutchinson MR, Wang X, Baratta MV, Hiranita T,
Cochran TA, Pomrenze MB, Galer EL, Kopajtic TA, Li CM,
Amat J, Larson G, Cooper DC, Huang Y, O’Neill CE, Yin H,
Zahniser NR, Katz JL, Rice KC, Maier SF, Bachtell RK, Watkins
LR (2015) DAT isn’t all that: cocaine reward and reinforcement
require toll-like receptor 4 signaling. Mol Psychiatry 20:1525–1537
Nunez YO, Mayfield RD (2012) Understanding alcoholism through
microRNA signatures in brains of human alcoholics. Front Genet
3:43
Nunez YO, Truitt JM, Gorini G, Ponomareva ON, Blednov YA, Harris
RA, Mayfield RD (2013) Positively correlated miRNA-mRNA reg-
ulatory networks in mouse frontal cortex during early stages of al-
cohol dependence. BMC Genomics 14:725
Oak S, Mandrekar P, Catalano D, Kodys K, Szabo G (2006) TLR2- and
TLR4-mediated signals determine attenuation or augmentation of
inflammation by acute alcohol in monocytes. J Immunol 176:
7628–7635
Obernier JA, Bouldin TW, Crews FT (2002a) Binge ethanol ex-
posure in adult rats causes necrotic cell death. Alcohol Clin
Exp Res 26:547–557
Obernier JA,White AM, Swartzwelder HS, Crews FT (2002b) Cognitive
deficits and CNS damage after a 4-day binge ethanol exposure in
rats. Pharmacol Biochem Behav 72:521–532
Obernier JA, White AM, Swartzwelder HS, Crews FT (2002c) Cognitive
deficits and CNS damage after a 4-day binge ethanol exposure in
rats. Pharmacol Biochem Behav 72:521–532
O’Connor JC, LawsonMA, Andre C, Moreau M, Lestage J, Castanon N,
Kelley KW, Dantzer R (2009) Lipopolysaccharide-induced depres-
sive-like behavior is mediated by indoleamine 2,3-dioxygenase ac-
tivation in mice. Mol Psychiatry 14:511–522
O’Connor RM, Gururajan A, Dinan TG, Kenny PJ, Cryan JF (2016) All
roads lead to the miRNome: miRNAs have a central role in the
molecular pathophysiology of psychiatric disorders. Trends
Pharmacol Sci 37:1029–1044
Okun E, Griffioen K, Barak B, Roberts NJ, Castro K, Pita MA, Cheng A,
Mughal MR, Wan R, Ashery U, Mattson MP (2010) Toll-like re-
ceptor 3 inhibits memory retention and constrains adult hippocam-
pal neurogenesis. Proc Natl Acad Sci U S A 107:15625–15630
Okvist A, Johansson S, Kuzmin A, Bazov I, Merino-Martinez R,
Ponomarev I, Mayfield RD, Harris RA, Sheedy D, Garrick T,
Harper C, Hurd YL, Terenius L, Ekstrom TJ, Bakalkin G,
Yakovleva T (2007) Neuroadaptations in human chronic alcoholics:
dysregulation of the NF-kappaB system. PLoS One 2:e930
Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcrip-
tion factors. Oncogene 18:6853–6866
Pandey SC, Sakharkar AJ, Tang L, Zhang H (2015) Potential role of
adolescent alcohol exposure-induced amygdaloid histone modifica-
tions in anxiety and alcohol intake during adulthood. Neurobiol Dis
82:607–619
Pascual M, Blanco AM, Cauli O, Minarro J, Guerri C (2007) Intermittent
ethanol exposure induces inflammatory brain damage and causes
long-term behavioural alterations in adolescent rats. Eur J
Neurosci 25:541–550
Pascual M, Balino P, Alfonso-Loeches S, Aragon CM, Guerri C (2011)
Impact of TLR4 on behavioral and cognitive dysfunctions associat-
ed with alcohol-induced neuroinflammatory damage. Brain Behav
Immun 25(Suppl 1):S80–S91
Pascual M, Balino P, Aragon CM, Guerri C (2015) Cytokines and
chemokines as biomarkers of ethanol-induced neuroinflammation
and anxiety-related behavior: role of TLR4 and TLR2.
Neuropharmacology 89:352–359
1496 Psychopharmacology (2017) 234:1483–1498
Pietri M, Schneider B, Mouillet-Richard S, Ermonval M, Mutel V,
Launay JM, Kellermann O (2005) Reactive oxygen species-
dependent TNF-alpha converting enzyme activation through stimu-
lation of 5-HT2B and alpha1D autoreceptors in neuronal cells.
FASEB J 19:1078–1087
Plane JM, Shen Y, Pleasure DE, Deng W (2010) Prospects for
minocycline neuroprotection. Arch Neurol 67:1442–1448
Qin L, Crews FT (2012a) Chronic ethanol increases systemic TLR3
agonist-induced neuroinflammation and neurodegeneration. J
Neuroinflammation 9:130
Qin L, Crews FT (2012b) NADPH oxidase and reactive oxygen species
contribute to alcohol-induced microglial activation and neurodegen-
eration. J Neuroinflammation 9:5
Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews
FT (2007) Systemic LPS causes chronic neuroinflammation and
progressive neurodegeneration. Glia 55:453–462
Qin L, He J, Hanes RN, PluzarevO, Hong JS, Crews FT (2008) Increased
systemic and brain cytokine production and neuroinflammation by
endotoxin following ethanol treatment. J Neuroinflammation 5:10
Qin L, Liu Y, Hong JS, Crews FT (2013) NADPH oxidase and aging
drive microglial activation, oxidative stress, and dopaminergic neu-
rodegeneration following systemic LPS administration. Glia 61:
855–868
Rea K, Dinan TG, Cryan JF (2016) The microbiome: a key regulator of
stress and neuroinflammation. Neurobiol Stress 4:23–33
Reissner KJ, Kalivas PW (2010) Using glutamate homeostasis as a target
for treating addictive disorders. Behav Pharmacol 21:514–522
Risher ML, Fleming RL, Boutros N, Semenova S, Wilson WA, Levin
ED, Markou A, Swartzwelder HS, Acheson SK (2013) Long-term
effects of chronic intermittent ethanol exposure in adolescent and
adult rats: radial-arm maze performance and operant food reinforced
responding. PLoS One 8:e62940
Risher ML, Sexton HG, Risher WC, Wilson WA, Fleming RL, Madison
RD, Moore SD, Eroglu C, Swartzwelder HS (2015) Adolescent
intermittent alcohol exposure: dysregulation of thrombospondins
and synapse formation are associated with decreased neuronal den-
sity in the adult hippocampus. Alcohol Clin Exp Res 39:2403–2413
Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I,
Krishnan V, Renthal W, Graham A, Birnbaum SG, Green TA,
Robison B, Lesselyong A, Perrotti LI, Bolanos CA, Kumar A,
Clark MS, Neumaier JF, Neve RL, Bhakar AL, Barker PA, Nestler
EJ (2009) Nuclear factor kappa B signaling regulates neuronal mor-
phology and cocaine reward. J Neurosci Off J Soc Neurosci 29:
3529–3537
Ryan SM, Nolan YM (2016) Neuroinflammation negatively affects adult
hippocampal neurogenesis and cognition: can exercise compensate?
Neurosci Biobehav Rev 61:121–131
Saha B,Momen-Heravi F, Kodys K, SzaboG (2016)MicroRNA cargo of
extracellular vesicles from alcohol-exposedmonocytes signals naive
monocytes to differentiate into M2 macrophages. J Biol Chem 291:
149–159
Sakharkar AJ, Vetreno RP, Zhang H, Kokare DM, Crews FT, Pandey SC
(2016) A role for histone acetylation mechanisms in adolescent al-
cohol exposure-induced deficits in hippocampal brain-derived neu-
rotrophic factor expression and neurogenesis markers in adulthood.
Brain Struct Funct
Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S,
Weisstaub N, Lee J, Duman R, Arancio O, Belzung C, Hen R
(2003) Requirement of hippocampal neurogenesis for the behavioral
effects of antidepressants. Science 301:805–809
Sarter M, Paolone G (2011) Deficits in attentional control: cholinergic
mechanisms and circuitry-based treatment approaches. Behav
Neurosci 125:825–835
Schoenbaum G, Saddoris MP, Ramus SJ, Shaham Y, Setlow B (2004)
Cocaine-experienced rats exhibit learning deficits in a task sensitive
to orbitofrontal cortex lesions. Eur J Neurosci 19:1997–2002
Schoenbaum G, Roesch MR, Stalnaker TA (2006) Orbitofrontal cortex,
decision-making and drug addiction. Trends Neurosci 29:116–124
Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G,
Suridjan I, Kennedy JL, Rekkas PV, Houle S,Meyer JH (2015) Role
of translocator protein density, a marker of neuroinflammation, in
the brain during major depressive episodes. JAMA Psychiatry 72:
268–275
Steptoe A, Hamer M, Chida Y (2007) The effects of acute psychological
stress on circulating inflammatory factors in humans: a review and
meta-analysis. Brain Behav Immun 21:901–912
Stevenson JR, Schroeder JP, Nixon K, Besheer J, Crews FT, Hodge CW
(2009) Abstinence following alcohol drinking produces depression-
like behavior and reduced hippocampal neurogenesis in mice.
Neuropsychopharmacology 34:1209–1222
Takeuchi O, Akira S (2010) Pattern recognition receptors and inflamma-
tion. Cell 140:805–820
Thakur V, McMullen MR, Pritchard MT, Nagy LE (2007) Regulation of
macrophage activation in alcoholic liver disease. J Gastroenterol
Hepatol 22(Suppl 1):S53–S56
Theberge FR, Li X, Kambhampati S, Pickens CL, St Laurent R, Bossert
JM, Baumann MH, Hutchinson MR, Rice KC, Watkins LR,
Shaham Y (2013) Effect of chronic delivery of the toll-like receptor
4 antagonist (+)-naltrexone on incubation of heroin craving. Biol
Psychiatry 73:729–737
Thomas JO, Stott K (2012) H1 and HMGB1: modulators of chromatin
structure. Biochem Soc Trans 40:341–346
Thounaojam MC, Kaushik DK, Basu A (2013) MicroRNAs in the
brain: it’s regulatory role in neuroinflammation. Mol
Neurobiol 47:1034–1044
Torres-Platas SG, Cruceanu C, Chen GG, Turecki G,Mechawar N (2014)
Evidence for increased microglial priming and macrophage recruit-
ment in the dorsal anterior cingulate white matter of depressed sui-
cides. Brain Behav Immun
Townshend JM,Duka T (2003)Mixed emotions: alcoholics’ impairments
in the recognition of specific emotional facial expressions.
Neuropsychologia 41:773–782
Tynan RJ, Naicker S, Hinwood M, Nalivaiko E, Buller KM, Pow DV,
Day TA, Walker FR (2010) Chronic stress alters the density and
morphology of microglia in a subset of stress-responsive brain re-
gions. Brain Behav Immun 24:1058–1068
Vabulas RM, Braedel S, Hilf N, Singh-Jasuja H, Herter S, Ahmad-Nejad
P, Kirschning CJ, DaCosta C, Rammensee HG,Wagner H, Schild H
(2002) The endoplasmic reticulum-resident heat shock protein Gp96
activates dendritic cells via the toll-like receptor 2/4 pathway. J Biol
Chem 277:20847–20853
Valenta JP, Gonzales RA (2016) Chronic intracerebroventricular infusion
of monocyte chemoattractant protein-1 leads to a persistent increase
in sweetened ethanol consumption during operant self-
administration but does not influence sucrose consumption in
long-Evans rats. Alcohol Clin Exp Res 40:187–195
Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De
Marchis F, Liu J, Antonelli A, Preti A, Raeli L, Shams SS, Yang H,
Varani L, Andersson U, Tracey KJ, Bachi A, Uguccioni M, Bianchi
ME (2012) Mutually exclusive redox forms of HMGB1 promote
cell recruitment or proinflammatory cytokine release. J Exp Med
209:1519–1528
Vetreno RP, Crews FT (2012) Adolescent binge drinking increases ex-
pression of the danger signal receptor agonist HMGB1 and toll-like
receptors in the adult prefrontal cortex. Neuroscience 226:475–488
Vetreno RP, Crews FT (2014) Current hypotheses on the mechanisms of
alcoholism. Handb Clin Neurol 125:477–497
Vetreno RP, Crews FT (2015) Binge ethanol exposure during adolescence
leads to a persistent loss of neurogenesis in the dorsal and ventral
hippocampus that is associated with impaired adult cognitive func-
tioning. Front Neurosci 9:35
Psychopharmacology (2017) 234:1483–1498 1497
Vetreno RP, Qin L, Crews FT (2013) Increased receptor for advanced
glycation end product expression in the human alcoholic prefrontal
cortex is linked to adolescent drinking. Neurobiol Dis 59:52–62
Vetreno RP, Broadwater M, Liu W, Spear LP, Crews FT (2014)
Adolescent, but not adult, binge ethanol exposure leads to persistent
global reductions of choline acetyltransferase expressing neurons in
brain. PLoS One 9:e113421
Vetreno RP, Patel Y, Patel U, Jordan Walter T, Crews FT (2016)
Adolescent intermittent ethanol reduces serotonin expression in the
adult raphe nucleus and upregulates innate immune expression that
is prevented by exercise. Brain Behav Immun
Volkow ND, Koob GF, McLellan AT (2016) Neurobiologic advances
from the brain disease model of addiction. N Engl J Med 374:
363–371
Ward RJ, Zhang Y, Crichton RR, Piret B, Piette J, de Witte P (1996)
Identification of the nuclear transcription factor NFkappaB in rat
after in vivo ethanol administration. FEBS Lett 389:119–122
Ward RJ, Colivicchi MA, Allen R, Schol F, Lallemand F, de Witte P,
Ballini C, Corte LD, Dexter D (2009) Neuro-inflammation in-
duced in the hippocampus of Bbinge drinking^ rats may be me-
diated by elevated extracellular glutamate content. J Neurochem
111:1119–1128
Weber MD, Frank MG, Tracey KJ, Watkins LR, Maier SF (2015) Stress
induces the danger-associated molecular pattern HMGB-1 in the
hippocampus of male Sprague-Dawley rats: a priming stimulus of
microglia and the NLRP3 inflammasome. J Neurosci 35:316–324
Weissenborn R, Duka T (2003) Acute alcohol effects on cognitive func-
tion in social drinkers: their relationship to drinking habits.
Psychopharmacology 165:306–312
White HR, Marmorstein NR, Crews FT, Bates ME, Mun EY, Loeber R
(2011) Associations between heavy drinking and changes in impul-
sive behavior among adolescent boys. Alcohol Clin Exp Res 35:
295–303
Wichers MC, Maes M (2004) The role of indoleamine 2,3-dioxygenase
(IDO) in the pathophysiology of interferon-alpha-induced depres-
sion. J Psychiatry Neurosci 29:11–17
Wilson JS, Mruthinti S, Buccafusco JJ, Schade RF, Mitchell MB, Harrell
DU, Gulati NK, Miller LS (2009) Anti-RAGE and Abeta immuno-
globulin levels are related to dementia level and cognitive perfor-
mance. J Gerontol A Biol Sci Med Sci 64:264–271
Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato
M, Lu Y, Hangai S, Koshiba R, Savitsky D, Ronfani L, Akira S,
Bianchi ME, Honda K, Tamura T, Kodama T, Taniguchi T (2009)
HMGB proteins function as universal sentinels for nucleic-acid-
mediated innate immune responses. Nature 462:99–103
Yang H, Lundback P, Ottosson L, Erlandsson-Harris H, Venereau E,
Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ
(2012) Redox modification of cysteine residues regulates the cyto-
kine activity of high mobility group box-1 (HMGB1). Mol Med 18:
250–259
Yelamanchili SV, Lamberty BG, Rennard DA, Morsey BM, Hochfelder
CG, Meays BM, Levy E, Fox HS (2015) MiR-21 in extracellular
vesicles leads to neurotoxicity via TLR7 signaling in SIV neurolog-
ical disease. PLoS Pathog 11:e1005032
Yirmiya R, Goshen I (2011) Immune modulation of learning, memory,
neural plasticity and neurogenesis. Brain Behav Immun 25:181–213
Young JJ, Bruno D, Pomara N (2014) A review of the relationship be-
tween proinflammatory cytokines and major depressive disorder. J
Affect Disord 169:15–20
Zou JY, Crews FT (2005) TNF alpha potentiates glutamate neurotoxicity
by inhibiting glutamate uptake in organotypic brain slice cultures:
neuroprotection by NF kappa B inhibition. Brain Res 1034:11–24
Zou J, Crews F (2006) CREB and NF-kappaB transcription factors reg-
ulate sensitivity to excitotoxic and oxidative stress induced neuronal
cell death. Cell Mol Neurobiol 26:385–405
Zou J, Crews F (2010) Induction of innate immune gene expression
cascades in brain slice cultures by ethanol: key role of NF-kappaB
and proinflammatory cytokines. Alcohol Clin Exp Res 34:777–789
Zou J, Crews FT (2012) Inflammasome-IL-1beta signaling mediates eth-
anol inhibition of hippocampal neurogenesis. Front Neurosci 6:77
Zou JY, Crews FT (2014) Release of neuronal HMGB1 by ethanol
through decreased HDAC activity activates brain neuroimmune sig-
naling. PLoS One 9:e87915
1498 Psychopharmacology (2017) 234:1483–1498
